Atlas Trials

Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Clinical trial NCT05130827 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05130827
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2021-12-21
Primary completion
2026-11-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.